Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuromyelitis Spectrum Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableUnknownNCT05414890
What this trial is testing

Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination

Who this might be right for
NMO Spectrum DisorderNMDA-R EncephalitisDiagnostic Self Evaluation+4 more
Beijing Tiantan Hospital 2,500
Large-scale testing (Phase 3)Active Not RecruitingNCT05314010
What this trial is testing

MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Beijing Mabworks Biotech Co., Ltd. 102
Not applicableStudy completedNCT03766347
What this trial is testing

Pediatric NMOSD Observational Study

Who this might be right for
Neuromyelitis OpticaNMO Spectrum Disorder
Mayo Clinic 100
Testing effectiveness (Phase 2)Looking for participantsNCT06697535
What this trial is testing

Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd 35
Post-approval studies (Phase 4)Active Not RecruitingNCT06180278
What this trial is testing

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 32
Not applicableLooking for participantsNCT06780709
What this trial is testing

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Icahn School of Medicine at Mount Sinai 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685678
What this trial is testing

Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)Ripertamab
Zhongming Qiu 20
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36
Large-scale testing (Phase 3)Study completedNCT02003144
What this trial is testing

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 119
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06561009
What this trial is testing

Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tianjin Medical University General Hospital 20
Not applicableLooking for participantsNCT05004493
What this trial is testing

Biorepository and Registry for Plasma Exchange Patients

Who this might be right for
Antibody-mediated RejectionNMO Spectrum DisorderTTP+1 more
Charles M Knudson 200
Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Not applicableUnknownNCT06068829
What this trial is testing

Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Feng Jinzhou 80
Not applicableLooking for participantsNCT04106830
What this trial is testing

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

Who this might be right for
NMO Spectrum DisorderMRIMultiple Sclerosis+1 more
Beijing Tiantan Hospital 1,000